Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
TRML on Nasdaq
There are no Buy or Sell transactions made by Clarus Defined Exit I, L.P. since 12/22/2023
Holdings reported by Clarus Defined Exit I, L.P. for Tourmaline Bio, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
160K |
$2.72M |
$16.99 |
May 11, 2021 |
Indirect |
|
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
May 11, 2021 |
Indirect |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
May 11, 2021 |
Indirect |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
May 11, 2021 |
Indirect |
Common Stock |
|
Transactions reported by Clarus Defined Exit I, L.P. for Tourmaline Bio, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.